NM_001354768.3:c.151C>A
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Moderate
The NM_001354768.3(NRL):c.151C>A(p.Pro51Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P51L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001354768.3 missense
Scores
Clinical Significance
Conservation
Publications
- retinitis pigmentosa 27Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- enhanced S-cone syndromeInheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001354768.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NRL | NM_001354768.3 | MANE Select | c.151C>A | p.Pro51Thr | missense | Exon 2 of 3 | NP_001341697.1 | ||
| NRL | NM_001354769.1 | c.151C>A | p.Pro51Thr | missense | Exon 3 of 4 | NP_001341698.1 | |||
| NRL | NM_006177.5 | c.151C>A | p.Pro51Thr | missense | Exon 3 of 4 | NP_006168.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NRL | ENST00000561028.6 | TSL:2 MANE Select | c.151C>A | p.Pro51Thr | missense | Exon 2 of 3 | ENSP00000454062.2 | ||
| NRL | ENST00000396997.1 | TSL:1 | c.151C>A | p.Pro51Thr | missense | Exon 3 of 4 | ENSP00000380193.1 | ||
| NRL | ENST00000397002.6 | TSL:1 | c.151C>A | p.Pro51Thr | missense | Exon 2 of 3 | ENSP00000380197.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 51 of the NRL protein (p.Pro51Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of autosomal dominant retinitis pigmentosa (PMID: 11879142; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 938373). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects NRL function (PMID: 17335001). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts the p.Pro51 amino acid residue in NRL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11385710, 21981118). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at